Formulation and analytical development for low-dose oral drug products

Oral controlled release formulation design and drug delivery theory to practice /
I whakaputaina: (2010)

Drug-membrane interactions analysis, drug distribution, modeling /
mā: Seydel, J. K. (Joachim Karl)
I whakaputaina: (2002)

Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)

Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)

Drug development principles, methodology and emerging challenges /
I whakaputaina: (2013)

Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)

Oral bioavailability basic principles, advanced concepts, and applications /
I whakaputaina: (2011)

Target validation in drug discovery
I whakaputaina: (2006)

Lead generation approaches in drug discovery
I whakaputaina: (2010)

Global new drug development : an introduction /
mā: Rosier, Jan A., me ētahi atu.
I whakaputaina: (2014)

ADME-enabling technologies for drug design and development
I whakaputaina: (2012)

A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
mā: Wallace, Rodrick
I whakaputaina: (2013)

A comprehensive guide to toxicology in preclinical drug development
I whakaputaina: (2013)

Introduction to biological and small molecule drug research and development theory and case studies /
I whakaputaina: (2013)

Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)

Analogue-based drug discovery III
I whakaputaina: (2013)

Drug metabolism prediction /
I whakaputaina: (2014)

Data mining in drug discovery /
I whakaputaina: (2014)

Statistical issues in drug development
mā: Senn, Stephen
I whakaputaina: (2007)

Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)

Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)

Early drug development strategies and routes to first-in-human trials /
I whakaputaina: (2010)

Molecular pathology in drug discovery and development
I whakaputaina: (2009)

Systems biology in drug discovery and development
I whakaputaina: (2011)

Drug discovery and design medical aspects /
I whakaputaina: (2002)

Peptide chemistry and drug design /
I whakaputaina: (2015)

Novel drug delivery approaches in dry eye syndrome therapy
I whakaputaina: (2010)

Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)

Drug utilization research : methods and applications /
I whakaputaina: (2016)

In silico lead discovery
mā: Miteva, Maria A.
I whakaputaina: (2011)

Life saving drugs the elusive magic bullet /
mā: Mann, J.
I whakaputaina: (2004)

Integrated pharmaceutics applied preformulation, product design, and regulatory science /
mā: Al-Achi, Antoine, 1955-
I whakaputaina: (2013)

Davis's drug guide for nurses /
mā: Deglin, Judith Hopfer, 1950-
I whakaputaina: (1993)

The quest for the cures the science, stories and struggles behind the next generation of medicines /
mā: Stockwell, Brent R.
I whakaputaina: (2011)

Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)

Adverse drug event reporting the roles of consumers and health-care professionals : workshop summary /
I whakaputaina: (2007)